Top

Published in:

Open Access 01-12-2014 | Research

Resveratrol potentiates effects of simvastatin on inhibition of rat ovarian theca-interstitial cells steroidogenesis

Authors: Israel Ortega, Jesus A Villanueva, Donna H Wong, Amanda B Cress, Anna Sokalska, Scott D Stanley, Antoni J Duleba

Published in: Journal of Ovarian Research | Issue 1/2014

Abstract

Background

Polycystic ovary syndrome (PCOS) is characterized by ovarian enlargement, hyperplastic theca compartment and increased androgen production due to, at least in part, excessive expression of several key genes involved in steroidogenesis. Previously, our group has demonstrated that simvastatin, competitive inhibitor of 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMG-CoA reductase), a rate-limiting step of the mevalonate pathway, reduces rat-theca interstitial cell steroidogenesis by inhibiting Cyp17a1 gene expression, the key enzyme of the androgen biosynthesis pathway. Recently, we demonstrated that resveratrol, a bioflavonoid abundant in red grapes, decreases rat theca-interstitial cell steroidogenesis and this suppressive effect is mediated through mechanisms independent of the mevalonate pathway. The present study evaluated the effect of combining simvastatin and resveratrol treatments on rat theca-interstitial cell steroidogenesis.

Methods

Rat theca-interstitial cells isolated from 30 day-old female rats were cultured for up to 48 h with or without simvastatin (1 μM) and/or resveratrol (3-10 μM). Steroidogenic enzymes gene expression was evaluated by quantitative real time PCR and steroid levels were measured by liquid chromatography-mass spectrometry. Comparisons between groups were performed using ANOVA and Tukey test.

Results

Resveratrol potentiated inhibitory effects of simvastatin on androstenedione and androsterone production in theca-interstitial cells. This suppressive effect correlated with profound inhibition in Cyp17a1 mRNA expression in the presence of a combination of resveratrol and simvastatin.

Conclusions

The present findings indicate that resveratrol potentiates the simvastatin-induced inhibitory effect on theca-interstitial cell androgen production, raising the possibility of development of novel treatments of PCOS.

Available only for authorised users

Parrott JA, Skinner MK: Developmental and hormonal regulation of keratinocyte growth factor expression and action in the ovarian follicle. Endocrinology 1998, 139: 228–235.PubMed

McAllister JM, Kerin JF, Trant JM, Estabrook RW, Mason JI, Waterman MR, Simpson ER: Regulation of cholesterol side-chain cleavage and 17 alpha-hydroxylase/lyase activities in proliferating human theca interna cells in long term monolayer culture. Endocrinology 1989, 125: 1959–1966.CrossRefPubMed

Wickenheisser JK, Nelson-Degrave VL, McAllister JM: Dysregulation of cytochrome P450 17alpha-hydroxylase messenger ribonucleic acid stability in theca cells isolated from women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005, 90: 1720–1727.CrossRefPubMed

Jakimiuk AJ, Weitsman SR, Navab A, Magoffin DA: Luteinizing hormone receptor, steroidogenesis acute regulatory protein, and steroidogenic enzyme messenger ribonucleic acids are overexpressed in thecal and granulosa cells from polycystic ovaries. J Clin Endocrinol Metab 2001, 86: 1318–1323.PubMed

Wickenheisser JK, Quinn PG, Nelson VL, Legro RS, Strauss JF 3rd, McAllister JM: Differential activity of the cytochrome P450 17alpha-hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells. J Clin Endocrinol Metab 2000, 85: 2304–2311.PubMed

Wachs DS, Coffler MS, Malcom PJ, Shimasaki S, Chang RJ: Increased androgen response to follicle-stimulating hormone administration in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2008, 93: 1827–1833.PubMedCentralCrossRefPubMed

Ravingerova T, Adameova A, Kelly T, Antonopoulou E, Pancza D, Ondrejcakova M, Khandelwal VK, Carnicka S, Lazou A: Changes in PPAR gene expression and myocardial tolerance to ischaemia: relevance to pleiotropic effects of statins. Can J Physiol Pharmacol 2009, 87: 1028–1036.CrossRefPubMed

Wolfrum S, Dendorfer A, Schutt M, Weidtmann B, Heep A, Tempel K, Klein HH, Dominiak P, Richardt G: Simvastatin acutely reduces myocardial reperfusion injury in vivo by activating the phosphatidylinositide 3-kinase/Akt pathway. J Cardiovasc Pharmacol 2004, 44: 348–355.CrossRefPubMed

Rzepczynska IJ, Piotrowski PC, Wong DH, Cress AB, Villanueva J, Duleba AJ: Role of isoprenylation in simvastatin-induced inhibition of ovarian theca-interstitial growth in the rat. Biol Reprod 2009, 81: 850–855.PubMedCentralCrossRefPubMed

10.

Ortega I, Cress AB, Wong DH, Villanueva JA, Sokalska A, Moeller BC, Stanley SD, Duleba AJ: Simvastatin reduces steroidogenesis by inhibiting Cyp17a1 gene expression in rat ovarian theca-interstitial cells. Biol Reprod 2012, 86: 1–9.CrossRefPubMed

11.

Banaszewska B, Pawelczyk L, Spaczynski RZ, Duleba AJ: Effects of simvastatin and metformin on polycystic ovary syndrome after six months of treatment. J Clin Endocrinol Metab 2011, 96: 3493–3501.PubMedCentralCrossRefPubMed

12.

Banaszewska B, Pawelczyk L, Spaczynski RZ, Duleba AJ: Comparison of simvastatin and metformin in treatment of polycystic ovary syndrome: prospective randomized trial. J Clin Endocrinol Metab 2009, 94: 4938–4945.PubMedCentralCrossRefPubMed

13.

Banaszewska B, Pawelczyk L, Spaczynski RZ, Dziura J, Duleba AJ: Effects of simvastatin and oral contraceptive agent on polycystic ovary syndrome: prospective, randomized, crossover trial. J Clin Endocrinol Metab 2007, 92: 456–461.CrossRefPubMed

14.

Culver AL, Ockene IS, Balasubramanian R, Olendzki BC, Sepavich DM, Wactawski-Wende J, Manson JE, Qiao Y, Liu S, Merriam PA, Rahilly-Tierny C, Thomas F, Berger JS, Ockene JK, Curb JD, Ma Y: Statin use and risk of diabetes mellitus in postmenopausal women in the women's health initiative. Arch Intern Med 2012, 172: 144–152.CrossRefPubMed

15.

Crandall JP, Oram V, Trandafirescu G, Reid M, Kishore P, Hawkins M, Cohen HW, Barzilai N: Pilot study of resveratrol in older adults with impaired glucose tolerance. J Gerontol A Biol Sci Med Sci 2012, 67: 1307–1312.PubMedCentralCrossRefPubMed

16.

Nambiar D, Rajamani P, Singh RP: Effects of phytochemicals on ionization radiation-mediated carcinogenesis and cancer therapy. Mutat Res 2011, 728: 139–157.CrossRefPubMed

17.

Gutierrez-Perez A, Cortes-Rojo C, Noriega-Cisneros R, Calderon-Cortes E, Manzo-Avalos S, Clemente-Guerrero M, Godinez-Hernandez D, Boldogh I, Saavedra-Molina A: Protective effects of resveratrol on calcium-induced oxidative stress in rat heart mitochondria. J Bioenerg Biomembr 2011, 43: 101–107.CrossRefPubMed

18.

Xuzhu G, Komai-Koma M, Leung BP, Howe HS, McSharry C, McInnes IB, Xu D: Resveratrol modulates murine collagen-induced arthritis by inhibiting Th17 and B-cell function. Ann Rheum Dis 2012, 71: 129–135.CrossRefPubMed

19.

Fabre KM, Saito K, Degraff W, Sowers AL, Thetford A, Cook JA, Krishna MC, Mitchell JB: The effects of resveratrol and selected metabolites on the radiation and antioxidant response. Cancer Biol Ther 2011, 12: 915–923.PubMedCentralCrossRefPubMed

20.

Wong DH, Villanueva JA, Cress AB, Duleba AJ: Effects of resveratrol on proliferation and apoptosis in rat ovarian theca-interstitial cells. Mol Hum Reprod 2010, 16: 251–259.PubMedCentralCrossRefPubMed

21.

Ortega I, Villanueva JA, Wong DH, Cress AB, Sokalska A, Stanley SD, Duleba AJ: Resveratrol reduces steroidogenesis in rat ovarian theca-interstitial cells: the role of inhibition of Akt/PKB signaling pathway. Endocrinology 2012, 153: 4019–4029.PubMedCentralCrossRefPubMed

22.

Penumathsa SV, Thirunavukkarasu M, Koneru S, Juhasz B, Zhan L, Pant R, Menon VP, Otani H, Maulik N: Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat. J Mol Cell Cardiol 2007, 42: 508–516.PubMedCentralCrossRefPubMed

23.

Wong DH, Villanueva JA, Cress AB, Sokalska A, Ortega I, Duleba AJ: Resveratrol inhibits the mevalonate pathway and potentiates the antiproliferative effects of simvastatin in rat theca-interstitial cells. Fertil Steril 2011, 96: 1252–1258.CrossRefPubMed

24.

Villanueva JA, Sokalska A, Cress AB, Ortega I, Bruner-Tran KL, Osteen KG, Duleba AJ: Resveratrol potentiates effect of simvastatin on inhibition of mevalonate pathway in human endometrial stromal cells. J Clin Endocrinol Metab 2013, 98: E455–462.PubMedCentralCrossRefPubMed

25.

Magoffin DA, Erickson GF: Purification of ovarian theca-interstitial cells by density gradient centrifugation. Endocrinology 1988, 122: 2345–2347.CrossRefPubMed

26.

Duleba AJ, Spaczynski RZ, Olive DL, Behrman HR: Effects of insulin and insulin-like growth factors on proliferation of rat ovarian theca-interstitial cells. Biol Reprod 1997, 56: 891–897.CrossRefPubMed

27.

Manna PR, Stocco DM: The role of specific mitogen-activated protein kinase signaling cascades in the regulation of steroidogenesis. J Signal Transduct 2011, 2011: 821615.PubMedCentralPubMed

28.

Stocco DM, Wang X, Jo Y, Manna PR: Multiple signaling pathways regulating steroidogenesis and steroidogenic acute regulatory protein expression: more complicated than we thought. Mol Endocrinol 2005, 19: 2647–2659.CrossRefPubMed

29.

Kwintkiewicz J, Foyouzi N, Piotrowski P, Rzepczynska I, Duleba AJ: Mevastatin inhibits proliferation of rat ovarian theca-interstitial cells by blocking the mitogen-activated protein kinase pathway. Fertil Steril 2006, 86: 1053–1058.CrossRefPubMed

30.

Do GM, Kwon EY, Kim HJ, Jeon SM, Ha TY, Park T, Choi MS: Long-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo E-deficient mice. Biochem Biophys Res Commun 2008, 374: 55–59.CrossRefPubMed

31.

Cho IJ, Ahn JY, Kim S, Choi MS, Ha TY: Resveratrol attenuates the expression of HMG-CoA reductase mRNA in hamsters. Biochem Biophys Res Commun 2008, 367: 190–194.CrossRefPubMed

32.

Gnoni GV, Paglialonga G: Resveratrol inhibits fatty acid and triacylglycerol synthesis in rat hepatocytes. European Journal Of Clinical Investigation 2009, 39: 211–218.CrossRefPubMed

33.

Fukuda S, Orisaka M, Tajima K, Hattori K, Kotsuji F: Luteinizing hormone-induced Akt phosphorylation and androgen production are modulated by MAP Kinase in bovine theca cells. Journal Of Ovarian Research 2009, 2: 17.PubMedCentralCrossRefPubMed

34.

Paul S, Kundu S, Pramanick K, Bandyopadhyay A, Mukherjee D: Regulation of ovarian steroidogenesis in vitro by gonadotropin in common carp Cyprinus carpio: interaction between calcium- and adenylate cyclase-dependent pathways and involvement of ERK signaling cascade. J Mol Endocrinol 2010, 45: 207–218.CrossRefPubMed

35.

De Luca A, Maiello MR, D'Alessio A, Pergameno M, Normanno N: The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches. Expert Opin Ther Targets 2012,16(Suppl 2):S17–27.CrossRefPubMed

36.

Chen YC, Nagpal ML, Stocco DM, Lin T: Effects of genistein, resveratrol, and quercetin on steroidogenesis and proliferation of MA-10 mouse Leydig tumor cells. J Endocrinol 2007, 192: 527–537.CrossRefPubMed

37.

van Ginkel PR, Sareen D, Subramanian L, Walker Q, Darjatmoko SR, Lindstrom MJ, Kulkarni A, Albert DM, Polans AS: Resveratrol inhibits tumor growth of human neuroblastoma and mediates apoptosis by directly targeting mitochondria. Clin Cancer Res 2007, 13: 5162–5169.CrossRefPubMed

38.

Walle T, Hsieh F, DeLegge MH, Oatis JE Jr, Walle UK: High absorption but very low bioavailability of oral resveratrol in humans. Drug Metabolism And Disposition: The Biological Fate Of Chemicals 2004, 32: 1377–1382.CrossRef

39.

Vitrac X, Desmouliere A, Brouillaud B, Krisa S, Deffieux G, Barthe N, Rosenbaum J, Merillon JM: Distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sci 2003, 72: 2219–2233.CrossRefPubMed

40.

Juan ME, Maijo M, Planas JM: Quantification of trans-resveratrol and its metabolites in rat plasma and tissues by HPLC. J Pharm Biomed Anal 2010, 51: 391–398.CrossRefPubMed

41.

Boocock DJ, Faust GE, Patel KR, Schinas AM, Brown VA, Ducharme MP, Booth TD, Crowell JA, Perloff M, Gescher AJ, Steward WP, Brenner DA: Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prev 2007, 16: 1246–1252.CrossRefPubMed

42.

Beedanagari SR, Bebenek I, Bui P, Hankinson O: Resveratrol inhibits dioxin-induced expression of human CYP1A1 and CYP1B1 by inhibiting recruitment of the aryl hydrocarbon receptor complex and RNA polymerase II to the regulatory regions of the corresponding genes. Toxicol Sci 2009, 110: 61–67.PubMedCentralCrossRefPubMed

43.

Chen ZH, Hurh YJ, Na HK, Kim JH, Chun YJ, Kim DH, Kang KS, Cho MH, Surh YJ: Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells. Carcinogenesis 2004, 25: 2005–2013.CrossRefPubMed

44.

Ciolino HP, Yeh GC: Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol. Mol Pharmacol 1999, 56: 760–767.PubMed

45.

Daneshmand S, Weitsman SR, Navab A, Jakimiuk AJ, Magoffin DA: Overexpression of theca-cell messenger RNA in polycystic ovary syndrome does not correlate with polymorphisms in the cholesterol side-chain cleavage and 17alpha-hydroxylase/C(17–20) lyase promoters. Fertil Steril 2002, 77: 274–280.CrossRefPubMed

46.

Rosenfield RL, Barnes RB, Ehrmann DA: Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism. J Clin Endocrinol Metab 1994, 79: 1686–1692.PubMed

Title: Resveratrol potentiates effects of simvastatin on inhibition of rat ovarian theca-interstitial cells steroidogenesis
Authors: Israel Ortega
Jesus A Villanueva
Donna H Wong
Amanda B Cress
Anna Sokalska
Scott D Stanley
Antoni J Duleba
Publication date: 01-12-2014
Publisher: BioMed Central
Published in: Journal of Ovarian Research / Issue 1/2014
Electronic ISSN: 1757-2215
DOI: https://doi.org/10.1186/1757-2215-7-21

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Resveratrol potentiates effects of simvastatin on inhibition of rat ovarian theca-interstitial cells steroidogenesis

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2014

Journal of Ovarian Research reviewer acknowledgement 2013

Co-administration of GnRH-agonist and hCG for final oocyte maturation (double trigger) in patients with low number of oocytes retrieved per number of preovulatory follicles-a preliminary report

Identification of differentially methylated genes in the malignant transformation of ovarian endometriosis

Krukenberg tumor presenting as back pain and a positive urine pregnancy test: a case report and literature review

Gemcitabine as a molecular targeting agent that blocks the Akt cascade in platinum-resistant ovarian cancer

Wnt/β-catenin pathway as a potential prognostic and predictive marker in patients with advanced ovarian cancer